Results 201 to 210 of about 235,597 (396)
Graphical abstract of the major mechanisms of Everolimus in ulcerative colitis: Everolimus, a selective mTORC1 inhibitor, protects against ulcerative colitis through a dual mechanism. First, Eve directly suppresses CLEC4E/Syk/NF‐κB signaling, thereby reducing pro‐inflammatory cytokine production and preserving intestinal barrier integrity.
Jing Chen +6 more
wiley +1 more source
Retraction Note: Trans-silencing effect of the 3'RR immunoglobulin heavy chain enhancer on Igκ transcription at the pro-B cell stage. [PDF]
Ghazzaui N +6 more
europepmc +1 more source
Localization of human variable and constant region immunoglobulin heavy chain genes on subtelomeric band q32 of chromosome 14 [PDF]
O. Wesley McBride +5 more
openalex +1 more source
ABSTRACT Non‐small cell lung cancer (NSCLC) is a common and fatal malignancy. This study aimed to elucidate the mechanism of Kruppel‐like factor (KLF1) in NSCLC progression. Clinical samples were collected, after which the expression levels of KLF1, LINC02159, and dynein cytoplasmic 1 heavy chain 1 (DYNC1H1) in tissues and cells were initially detected,
Han Yang
wiley +1 more source
R. Taub +7 more
semanticscholar +1 more source
Several aspects of the history of polymer science in Karlsruhe are presented. Over the last 125 years, very famous polymer scientists worked as professors in Karlsruhe, for example: Hermann Staudinger, Leo Ubbelohde, Hermann Franz Mark, and Werner Kuhn. These and other researchers are portrayed. Scientists working in Karlsruhe contributed substantially
Manfred Wilhelm
wiley +1 more source
Acute leukemias associated with the 4;11 chromosome translocation have rearranged immunoglobulin heavy chain genes [PDF]
WM Crist +8 more
openalex +1 more source
Protein glycosylation in lung cancer from a mass spectrometry perspective
Abstract Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi +2 more
wiley +1 more source

